Cell Cycle and Regulation — MCQs
Li–Fraumeni syndrome is associated with mutations in which of the following genes?
Which enzymatic activity is primarily responsible for the immortality of cancer cells?
Which HPV oncoprotein initiates cervical carcinogenesis primarily by inactivating the p53 tumor suppressor?
Which phase of the cell cycle does not have a fixed duration?
Identify the gene commonly involved in the condition shown in the image?
In which type of lung carcinoma is the p53 mutation most commonly observed?
When two different chemicals act on two different receptors and their responses are opposite to each other on the same cell, this phenomenon is called?
Which ion movement is primarily responsible for hyperpolarization of the cell membrane?
Cells are most sensitive to ionizing radiation during which phase?
Enzymes of glycolysis are found in:
Cell Cycle and Regulation Indian Medical PG Practice Questions and MCQs
Question 1: Li–Fraumeni syndrome is associated with mutations in which of the following genes?
- A. Gene RB1
- B. Gene BRCA1
- C. Gene P21
- D. Gene TP53 (Correct Answer)
Explanation: ***Gene TP53*** - Li-Fraumeni syndrome is a rare, inherited cancer susceptibility syndrome associated with germline mutations in the **TP53 tumor suppressor gene**. - The **TP53 gene** encodes the p53 protein, which plays a critical role in cell cycle arrest, DNA repair, and initiation of apoptosis in response to cellular stress, thus preventing tumor formation. *Gene P21* - The **p21 gene** (CDKN1A) is a cyclin-dependent kinase inhibitor that acts downstream of p53, mediating p53-induced cell cycle arrest. - While p21 is involved in the p53 pathway, mutations in p21 itself are not the primary cause of Li-Fraumeni syndrome. *Gene RB1* - The **RB1 gene** encodes the retinoblastoma protein, a tumor suppressor involved in cell cycle regulation, particularly in controlling passage from G1 to S phase. - Mutations in **RB1** are primarily associated with hereditary retinoblastoma and osteosarcoma, not Li-Fraumeni syndrome. *Gene BRCA1* - The **BRCA1 gene** is a tumor suppressor gene involved in DNA repair, especially homologous recombination. - Germline mutations in **BRCA1** are strongly associated with hereditary breast and ovarian cancer syndrome, not Li-Fraumeni syndrome.
Question 2: Which enzymatic activity is primarily responsible for the immortality of cancer cells?
- A. RNA polymerase
- B. Telomerase (Correct Answer)
- C. DNA polymerase
- D. DNA reverse transcriptase
Explanation: ***Telomerase*** - **Telomerase** is an enzyme that adds repetitive nucleotide sequences to the ends of chromosomes (**telomeres**), preventing their shortening during DNA replication [1]. - In normal somatic cells, **telomerase** activity is low or absent, leading to progressive telomere shortening and eventual cellular senescence or apoptosis; however, in cancer cells, **telomerase** is highly active, maintaining telomere length and enabling indefinite cell division, contributing to their **immortality** [1]. *DNA reverse transcriptase* - **DNA reverse transcriptase** synthesizes DNA from an RNA template, a process characteristic of retroviruses (e.g., HIV) and not typically involved in the immortality of human cancer cells. - While some endogenous retroelements exist in the human genome, this enzyme's primary role is not in maintaining the replicative potential of cancer cells. *RNA polymerase* - **RNA polymerase** is responsible for synthesizing RNA from a DNA template (**transcription**), a fundamental process in gene expression. - While critical for cell growth and division, **RNA polymerase** does not directly prevent telomere shortening or contribute to cellular immortality. *DNA polymerase* - **DNA polymerase** is involved in DNA replication and repair, synthesizing new DNA strands and ensuring genetic fidelity. - While essential for cell proliferation, it does not directly address the issue of **telomere shortening**, which is key to cellular aging and immortality. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 311-312.
Question 3: Which HPV oncoprotein initiates cervical carcinogenesis primarily by inactivating the p53 tumor suppressor?
- A. E3
- B. E5
- C. E6 (Correct Answer)
- D. E7
Explanation: ***E6*** - **E6 oncoprotein is the HPV protein that specifically targets and degrades p53** through ubiquitin-mediated proteolysis [2]. - **p53 degradation** prevents apoptosis and allows cells with damaged DNA to survive and proliferate, a critical early step in malignant transformation [3]. - E6 works synergistically with E7 in cervical carcinogenesis, but **E6 is uniquely responsible for p53 inactivation** [1]. *E3* - HPV does not have a clinically significant E3 oncoprotein in the context of cervical cancer pathogenesis. - This is not a major viral oncoprotein involved in malignant transformation. *E5* - **E5 oncoprotein** plays a minor role in early infection by enhancing growth factor receptor signaling. - It does **not target p53** and is often lost during viral integration, making it less critical for malignant progression. *E7* - **E7 oncoprotein targets the retinoblastoma protein (Rb)**, not p53 [1]. - Rb inactivation releases E2F transcription factors, driving cell cycle progression [1]. - E7 and E6 work together, but **E7's specific target is Rb, not p53** [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 334-335. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Female Genital Tract, pp. 1006-1007. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 303-304.
Question 4: Which phase of the cell cycle does not have a fixed duration?
- A. S phase (DNA synthesis)
- B. M phase (mitosis)
- C. G1 phase (cell growth) (Correct Answer)
- D. G2 phase (preparation for mitosis)
Explanation: ***G1*** - The **G1 phase** of the cell cycle is variable in length and can differ significantly between cell types and conditions, unlike S, M, and G2 phases [1][2]. - Cells can spend an **indeterminate amount of time** in G1, depending on factors like nutrients and signals for division [2]. *S* - The **S phase** is characterized by a fixed duration where **DNA replication** occurs, and is critical for cell division [1]. - It typically has a well-defined time frame in the cell cycle that is consistent across different cells [1]. *M* - The **M phase** (mitosis) requires a set duration to ensure that the **cell divides** accurately and equally into two daughter cells [2]. - Fluctuations in this phase can result in aberrant cell division and aneuploidy. *G2* - The **G2 phase** also has a consistent timeframe dedicated to preparing the cell for mitosis, focusing on DNA repair and organelle duplication [2]. - The cell ensures readiness for division during this phase, which is critical for genomic integrity. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 78-79. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 37-38.
Question 5: Identify the gene commonly involved in the condition shown in the image?
- A. RAS
- B. RET
- C. BRAF V600E (Correct Answer)
- D. P53
Explanation: ***BRAF V600E*** - The image displays cells with **Langerhans cell morphology**, including folded nuclei and abundant pale cytoplasm, which are characteristic of **Langerhans cell histiocytosis (LCH)** [1]. - The **BRAF V600E mutation** is the most common genetic alteration found in LCH, present in about 50-60% of cases and activating the MAPK pathway [1]. *RAS* - **RAS mutations** are frequently seen in various cancers, including colorectal adenocarcinoma, pancreatic adenocarcinoma, and non-small cell lung cancer. - While RAS pathway activation can occur in LCH, a direct RAS mutation is not the most common genetic driver; rather, downstream effectors like BRAF V600E are more prominent [1]. *RET* - **RET mutations** are primarily associated with **medullary thyroid carcinoma** (in both sporadic and inherited forms like MEN 2A and MEN 2B) and can also be found in certain types of lung cancer. - They are not a characteristic genetic alteration for Langerhans cell histiocytosis. *P53* - The **TP53 gene** encodes the tumor suppressor protein p53, and mutations in this gene are among the most frequent genetic alterations across a wide spectrum of human cancers. - Although p53 plays a critical role in cell cycle regulation and apoptosis, it is not a primary or common driver mutation specifically associated with Langerhans cell histiocytosis [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 629-630.
Question 6: In which type of lung carcinoma is the p53 mutation most commonly observed?
- A. Adenocarcinoma
- B. Squamous cell carcinoma (SCC) (Correct Answer)
- C. Large cell carcinoma
- D. Small cell carcinoma
Explanation: ***Small cell carcinoma*** - **Small cell lung carcinoma (SCLC)** has the highest frequency of **p53 mutations**, occurring in approximately **90-95%** of cases. - These mutations are associated with the **aggressive nature** and **poor prognosis** of SCLC, contributing to its rapid growth and early metastasis. *Adenocarcinoma* - **Adenocarcinoma** has p53 mutations in approximately **50-60%** of cases, which is less frequent than SCLC. - This subtype is more commonly associated with **EGFR mutations** and **ALK rearrangements**, particularly in non-smokers. *Squamous cell carcinoma (SCC)* - **Squamous cell carcinoma** shows p53 mutations in about **70-80%** of cases, but still lower than SCLC. - It is more strongly associated with **smoking** and often displays mutations in **CDKN2A** and **PIK3CA** pathways. *Large cell carcinoma* - **Large cell carcinoma** has variable p53 mutation rates, typically **40-60%** of cases. - This subtype is less well-characterized molecularly and represents a **diagnosis of exclusion** among lung cancers.
Question 7: When two different chemicals act on two different receptors and their responses are opposite to each other on the same cell, this phenomenon is called?
- A. Physiological antagonism (Correct Answer)
- B. Chemical antagonism
- C. Reversible antagonism
- D. Competitive antagonism
Explanation: ***Physiological antagonism*** - This occurs when two drugs act on **different receptors** to produce **opposite physiological effects** within the same system or cell, effectively canceling each other out [1]. - A classic example is the opposing actions of **histamine** (causing bronchoconstriction) and **adrenaline** (causing bronchodilation) on the bronchi [1]. *Chemical antagonism* - This involves a direct **chemical interaction** between two drugs that results in the **inactivation of one or both** of them. - An example is the binding of **chelating agents** to heavy metals, forming an inert complex. *Reversible antagonism* - This describes antagonism where the antagonist binds to the receptor and can be **displaced by a higher concentration of the agonist**. - It does not specifically describe antagonists acting on different receptors or producing opposing physiological effects. *Competitive antagonism* - This occurs when an antagonist directly **competes with an agonist for the same binding site** on a receptor [1]. - The antagonist, while not producing a response itself, prevents the agonist from binding and activating the receptor.
Question 8: Which ion movement is primarily responsible for hyperpolarization of the cell membrane?
- A. Chloride (Cl-) influx
- B. Potassium (K+) efflux (Correct Answer)
- C. Sodium (Na+) influx
- D. None of the options
Explanation: ***Potassium (K+) efflux*** - **Potassium efflux** (K+ leaving the cell) is the **primary mechanism** responsible for hyperpolarization of the cell membrane across most cell types. - When K+ channels open, positive charges leave the cell, making the intracellular environment more negative relative to the extracellular space, thereby **hyperpolarizing** the membrane. - This mechanism is responsible for: - **Afterhyperpolarization** following action potentials - Setting the **resting membrane potential** close to the K+ equilibrium potential (-90 mV) - **Repolarization and hyperpolarization phases** of action potentials - Examples include delayed rectifier K+ channels and calcium-activated K+ channels. *Chloride (Cl-) influx* - While Cl- influx can cause hyperpolarization (especially through **GABA-A receptors** in neurons), it is a **secondary or specialized mechanism**, not the primary one. - In many mature neurons, the Cl- equilibrium potential is close to the resting potential, limiting its hyperpolarizing effect. - This mechanism is important in **inhibitory neurotransmission** but not universally across all cell types. *Sodium (Na+) influx* - **Sodium influx** through voltage-gated sodium channels is responsible for the **depolarization phase** of an action potential. - This makes the inside of the cell significantly more positive (+30 to +40 mV), which is the opposite of hyperpolarization. *None of the options* - This option is incorrect because **potassium efflux** is indeed the primary mechanism for membrane hyperpolarization.
Question 9: Cells are most sensitive to ionizing radiation during which phase?
- A. S phase
- B. G2M phase (Correct Answer)
- C. G0 phase
- D. G1 phase
Explanation: ***G2M phase*** - Cells are most sensitive to ionizing radiation during the **G2 phase** and **M phase** (mitosis) due to the highly condensed chromatin structure and active DNA repair mechanisms being less efficient [2], [3]. - During G2, DNA synthesis is complete, and the cell is preparing for division, making DNA damage particularly detrimental and harder to repair without compromising cell viability [2]. *S phase* - Cells in the **S phase** (DNA synthesis phase) are relatively radioresistant because of active **DNA replication** and associated repair mechanisms. - These repair pathways are highly efficient at correcting DNA damage during replication, making the cell less susceptible to radiation-induced lethality. *G1 phase* - Cells in the **G1 phase** (first gap phase) show intermediate radiosensitivity. - While less sensitive than G2/M phases, G1 cells are more vulnerable than those in late S phase due to active metabolic preparation for DNA synthesis [1]. *G0 phase* - Cells in the **G0 phase** (quiescent phase) are generally **radioresistant** because they are not actively dividing or synthesizing DNA [3]. - They have ample time for DNA repair before re-entering the cell cycle, and their DNA structure is less vulnerable than during active division [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 302-303. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 37-38. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Central Nervous System Synapse, pp. 436-437.
Question 10: Enzymes of glycolysis are found in:
- A. Cytosol (Correct Answer)
- B. Cell membrane
- C. Mitochondria
- D. Ribosomes
Explanation: ***Cytosol*** - Glycolysis is a metabolic pathway that occurs in the **cytosol** of cells. - All the enzymes required for the conversion of glucose to pyruvate are freely dissolved in the **cytoplasm**. *Cell membrane* - The cell membrane is primarily involved in **regulating the passage of substances** into and out of the cell, as well as cell signaling. - Glycolytic enzymes are not associated with the cell membrane. *Mitochondria* - Mitochondria are the primary site of **oxidative phosphorylation** and the **citric acid cycle**, not glycolysis. - While pyruvate (the end product of glycolysis) moves into the mitochondria for further metabolism, the initial glycolytic steps do not occur there. *Ribosomes* - Ribosomes are responsible for **protein synthesis** (translation). - They do not contain enzymes for metabolic pathways like glycolysis.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free